Abstract:Emerging evidence suggests that accumulation of oxidative DNA damage in nuclear genome is an important contributing factor in neuronal cell death after cerebral ischemia. It has been shown in various models of cerebral ischemia/reperfusion that there is accumulation of oxidative DNA base damage and apurinic/apyridinic abasic site (AP site) in injured neurons, which could mediate neuronal degeneration by triggering various pro-apoptotic molecules. In the brain most types of oxidative DNA damage are repaired via the base-excision repair (BER) pathway that is highly inducible in response to various sublethal stimuli. Thus, interventions that enhance the activity of the BER pathway may be a potential therapeutic strategy against ischemic cell death. In the present study, we have examined the neuroprotective effect of the neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP) in the rat model of transient global cerebral ischemia. Further, we have investigated the role of BER regulation as a potential mechanism underlying the effect of PACAP. PACAP, when infused intracerebroventricularly in the rat, potently protected against CA1 neuronal cell death after global cerebral ischemia produced by 12 minutes of 4-vessel occlusion. Associated with this neuroprotection, PACAP treatment reduced the accumulation of oxidative DNA lesions, especially AP site, and subsequently attenuated the activation of pro-apoptotic molecules p53 and PUMA in the CA1 sector, suggesting that the effect of PACAP may involve the acceleration of the repair process of endogenous oxidative DNA damage. To investigate the underlying mechanism, cellular BER activity and the expression of BER enzymes were measured in the hippocampal extracts. The results revealed that PACAP markedly enhanced the hippocampal expression (at both mRNA and protein levels) and activities of the essential BER enzymes AP endonuclase (APE) and DNA polymerase-beta. Furthermore, based on the results of inhibition studies, the inducible effect of PACAP on the BER pathway was found to be dependent on the phosphorylation and nuclear translocation of cAMP-response-element-binding protein (CREB), which mediated the enhanced transcription of both APE and DNA polymerase-beta. Finally, the effect of PACAP on BER and neuroprotection was mimicked by the administration of a cAMP/protein kinase A (PKA) agonist. The results of the present study demonstrate the neuroprotective effect of PACAP in hippocampal CA1 neurons after transient global cerebral ischemia. The effect of PACAP is dependent on the activation and nuclear translocation of CREB, and involves CREB-mediated activation of BER pathway for endogenous DNA repair. The results suggest that enhancement of neuronal DNA repair capacity by PACAP or other means may be a novel potential therapeutic approach to limit ischemic neuronal loss. (This project was supported by NIH grants NS36736, NS38560, NS 43802, and NS45048).

Dibutyryl Cyclic Adenosine Monophosphate Rescues the Neurons From Degeneration in Stab Wound and Excitotoxic Injury Models

Tetradecyl 2,3-Dihydroxybenzoate Promotes Functional Recovery after Spinal Cord Injury in Adult Rats

Effects of Retrograde Gene Transfer of Brain-Derived Neurotrophic Factor in the Rostral Spinal Cord of a Compression Model in Rat

Meglumine cyclic adenylate improves neurological function following acute spinal cord injury in rats.

Involvement of cAMP in neuronal survival and axonal regeneration

NeuroAiDTM-II (MLC901) Promoted Neurogenesis by Activating the PI3K/AKT/GSK-3β Signaling Pathway in Rat Spinal Cord Injury Models

Cyclic AMP promotes axon regeneration, lesion repair and neuronal survival in lampreys after spinal cord injury

Intraocular Elevation of Cyclic AMP Potentiates Ciliary Neurotrophic Factor-Induced Regeneration of Adult Rat Retinal Ganglion Cell Axons

In vitro beneficial activation of microglial cells by mechanically-injured astrocytes enhances the synthesis and secretion of BDNF through p38MAPK.

Neuroprotective Effects of Carbonic Anhydrase Inhibition and Cyclic Adenosine Monophosphate Activation in Mouse Model of Transient Global Cerebral Ischemia and Reperfusion

Treatment with the Ketone Body D-β-hydroxybutyrate Attenuates Autophagy Activated by NMDA and Reduces Excitotoxic Neuronal Damage in the Rat Striatum In Vivo

Neuroprotection against ischemic CA1 neurodegeneration by pituitary adenylate cyclase activating polypeptide via cAMP-response-element-binding protein-mediated enhancement of endogenous DNA repair

Sustained Delivery of Dbcamp by Poly(propylene Carbonate) Micron Fibers Promotes Axonal Regenerative Sprouting and Functional Recovery after Spinal Cord Hemisection

Epac2 Elevation Reverses Inhibition by Chondroitin Sulfate Proteoglycans In Vitro and Transforms Postlesion Inhibitory Environment to Promote Axonal Outgrowth in an Ex Vivo Model of Spinal Cord Injury

Molecular Mechanisms Underlying Effects Of Neural Stem Cells Against Traumatic Axonal Injury

Meglumine cyclic adenylate improves cardiovascular hemodynamics and motor-function in a rat model of acute T4 thoracic spinal cord injury

Neural Stem Cells Overexpressing Arginine Decarboxylase Improve Functional Recovery from Spinal Cord Injury in a Mouse Model

Role of combination of methylprednisolone and adipose-derived stem cells (ADSCs) overexpressing brain-derived neurotrophic factor(BDNF) in the treatment of acute spinal cord injury of rats

Pituitary Adenylate Cyclase Activating Polypeptide Elicits Neuroprotection Against Acute Ischemic Neuronal Cell Death Associated with NMDA Receptors

Recombinant AAV-mediated Expression of Human BDNF Protects Neurons Against Cell Apoptosis in Aβ-induced Neuronal Damage Model

Role of the AMPK signaling pathway in early brain injury after subarachnoid hemorrhage in rats